Drugs / Ningmitai capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06064448 | Mar 2019 → Dec 2022 | chronic prostatitis, erectile dysfunction | Xintian Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ningmitai capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06064448 ↗ |
| Known as | NMT | “AIM: To assess the efficacy of Ningmitai capsule (NMT), an oral traditional Chinese herbal formulation, combined with sildenafil versus monotherapy in alleviating symptoms...” PMID 40365426 ↗ May 2025 |
| Modality | Traditional medicine (herbal / TCM) | “an oral traditional Chinese herbal formulation” PMID 40365426 ↗ May 2025 |
| Route | Oral | “The subjects took Ningmitai capsule orally, 0.38 g/capsule, 3 times a day, 4 capsules each time, and took it after meals.” NCT06064448 ↗ |